Bank of New York Mellon Corp - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 124 filers reported holding IMMUNOVANT INC in Q3 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$7,379,096
+113.1%
192,214
+5.3%
0.00%
+100.0%
Q2 2023$3,463,278
+32.1%
182,566
+8.0%
0.00%0.0%
Q1 2023$2,622,338
-11.8%
169,074
+0.9%
0.00%0.0%
Q4 2022$2,973,303
+256.1%
167,510
+11.9%
0.00%
Q3 2022$835,000
+51.3%
149,674
+5.8%
0.00%
Q2 2022$552,000
-31.8%
141,433
-3.7%
0.00%
Q1 2022$809,000
-34.9%
146,799
+0.6%
0.00%
Q4 2021$1,243,000
+1.8%
145,866
+3.8%
0.00%
Q3 2021$1,221,000
-6.0%
140,473
+14.3%
0.00%
Q2 2021$1,299,000
-45.6%
122,868
-17.5%
0.00%
Q1 2021$2,389,000
-69.0%
148,950
-10.9%
0.00%
-100.0%
Q4 2020$7,718,000
+42.0%
167,111
+8.2%
0.00%
+100.0%
Q3 2020$5,434,000
+197.1%
154,446
+105.6%
0.00%
Q2 2020$1,829,00075,1040.00%
Other shareholders
IMMUNOVANT INC shareholders Q3 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,510,412$264,291,0006.36%
Ghost Tree Capital, LLC 525,000$18,475,0005.34%
Pinz Capital Management, LP 199,100$7,006,0002.56%
ACUTA CAPITAL PARTNERS, LLC 250,000$8,798,0002.39%
BVF INC/IL 1,198,427$42,173,0002.30%
Cormorant Asset Management, LP 1,637,951$57,639,0002.22%
Vivo Capital, LLC 1,042,460$36,684,0002.12%
Parkman Healthcare Partners LLC 150,151$5,284,0001.40%
MANGROVE PARTNERS IM, LLC 230,307$8,105,0001.02%
Ikarian Capital, LLC 321,887$11,328,0000.82%
View complete list of IMMUNOVANT INC shareholders